Stocks · Health care · Pharmaceutical Preparations

Nurix Therapeutics, Inc.

NRIX Clue Score49
United States Fiscal year ends November CIK 0001549595 Results filed 13 Oct 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Gwenn Hansen
3 Feb 2026
Chief Scientific Officer
Exercised, kept
31,333
$0.84
$26.32K
Julia P Gregory
17 Sep 2025
Director
Exercised, kept
10,750
$1.86
$20.00K
Houte Hans van
31 May 2022
Chief Financial Officer
Exercised, kept
68,333
$0.84
$57.40K
Pierre Beaurang
25 Mar 2021
Chief Business Officer
Exercised, kept
4,330
$0.84
$3.64K
Gwenn Hansen
30 Nov 2020
Chief Scientific Officer
Exercised, kept
12,000
$0.84
$10.08K

What was left out

Form 4 filings counted 250
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 29
Sales straight out of an exercise 152
Sales at will 22
Transactions with no price 0
Shares from compensation/vesting 32,348,104
Sales filed before the plan box existed 12
History held since 29 Jul 2020